FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series C / Biotech startups that raised Series C in Zhejiang, China

Biotech startups that raised Series C in Zhejiang, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series C in Zhejiang, China
One-time CSV
  • 23 funded companies, 20 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-c~zhejiang-china.csv23 rows × 18 columns
CompanyCityLast roundAmountDate
AusperBioHangzhouSeries C$120.0M2026-08-27
Healsun BiopharmHangzhouSeries C$27.8M2025-11-19
DIAGENSHangzhouSeries C$14.1M2023-12-29
LYNK PharmaceuticalsHangzhouSeries C$16.7M2023-09-21
Konfoong Biotech InternationalNingboSeries C$14.9M2022-07-12

5 rows of the CSV in 5 of its 18 columns.

23
Startups
$1.1B
Total raised
6
Funded in the last 12 months
$221.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

5 of 23
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
Healsun Biopharm Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. Biotech Hangzhou Series C $27.8M 2025-11-19 $101.3M Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 251 to 500 2015
DIAGENS DIAGENS is a Hangzhou-based biotechnology firm that provides in-vitro diagnostic products and medical equipment. Biotech Hangzhou Series C $14.1M 2023-12-29 Shenzhen Guozhong Venture Capital Management, Haiyuan Capital, China Venture Capital HRVC +2 51 to 100 2014
LYNK Pharmaceuticals LYNK Pharmaceuticals is a biotech company that discovers and develops new medicines. Biotech Hangzhou Series C $16.7M 2023-09-21 Legend Capital, Kaitai Capital, New Alliance Capital +2 11 to 50 2018
Konfoong Biotech International Konfoong Biotech International is a biotechnology company. Artificial intelligence Ningbo Series C $14.9M 2022-07-12 Intel Capital, Yinxinggu Capital 101 to 250 2011

Table 1. Biotech startups that raised Series C in Zhejiang, China: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
2 Healsun Biopharm Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. Biotech Hangzhou Series C $27.8M 2025-11-19 $101.3M Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 251 to 500 2015

Table 2. Biotech startups that raised Series C in Zhejiang, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Yinxinggu Capital Venture capital firm Hangzhou, China 2 9% 1 Healsun Biopharm
2 Qiming Venture Partners Venture capital firm Shanghai, China 1 4% 1 AusperBio
3 Hankang Capital Venture capital firm Shanghai, China 1 4% 1 AusperBio
4 BioVenture Venture capital firm Suzhou, China 1 4% 1 AusperBio
5 Genesis Capital Private equity firm Central, Hong Kong 1 4% 1 AusperBio
6 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China 1 4% 1 Healsun Biopharm
7 Haibang Capital Venture capital firm Hangzhou, China 1 4% 1 Healsun Biopharm
8 Dongfang Jiafu Private equity firm Hangzhou, China 1 4% 1 Healsun Biopharm
9 Haitong Capital Private equity firm Lisbon, Portugal 1 4% 1 Healsun Biopharm
10 Prox Ventures Venture capital firm Shanghai, China 1 4%
11 Qianhai Fund of Funds Private equity firm Shanzhen, China 1 4%
12 CD Capital Venture capital firm Shanghai, China 1 4%
13 Puhua Capital Venture capital firm Hangzhou, China 1 4%
14 China Venture Capital HRVC Private equity firm Nanjing, China 1 4%
15 Shenzhen Guozhong Venture Capital Management Venture capital firm Shenzhen, China 1 4%

Table 3. Biotech startups that raised Series C in Zhejiang, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 23 100% $1.1B
Hardware 1 4%
Artificial intelligence 1 4%
Software 1 4%

Table 4. Biotech startups that raised Series C in Zhejiang, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 23 100% $29.6M

Table 5. Biotech startups that raised Series C in Zhejiang, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Hangzhou 20 87%
Ningbo 2 9%
Deqing 1 4%

Table 6. Biotech startups that raised Series C in Zhejiang, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 2 33% $149.6M
June 2026 2 33% $44.3M
December 2025 1 17%
November 2025 1 17% $27.8M

Table 7. Biotech startups that raised Series C in Zhejiang, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 17% $193.9M
2025 6 26% $167.5M
2024 1 4%
2023 2 9% $30.8M
2022 4 17% $62.3M
2021 4 17% $318.2M

Table 8. Biotech startups that raised Series C in Zhejiang, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 1 4%
2015 to 2019 9 39%
2010 to 2014 11 48%
Before 2010 2 9%

Table 9. Biotech startups that raised Series C in Zhejiang, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 3 13%
11 to 50 6 26%
51 to 100 9 39%
101 to 250 2 9%
251 to 500 2 9%
501 to 1,000 1 4%

Table 10. Biotech startups that raised Series C in Zhejiang, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Zhejiang, China whose last round is Series C are on the list?
23, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series C in Zhejiang, China: 23 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Zhejiang

Other sectors that raised Series C in Zhejiang

Cite: FundingWatcher, 23 biotech companies in Zhejiang, China whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-c/zhejiang-china/